share_log

Shareholders in Scotts Miracle-Gro (NYSE:SMG) Are in the Red If They Invested Three Years Ago

Shareholders in Scotts Miracle-Gro (NYSE:SMG) Are in the Red If They Invested Three Years Ago

如果三年前进行投资,Scotts Miracle-Gro(纽约证券交易所代码:SMG)的股东将处于亏损状态
Simply Wall St ·  02/14 06:44

As an investor, mistakes are inevitable. But you have a problem if you face massive losses more than once in a while. So take a moment to sympathize with the long term shareholders of The Scotts Miracle-Gro Company (NYSE:SMG), who have seen the share price tank a massive 76% over a three year period. That would be a disturbing experience. And more recent buyers are having a tough time too, with a drop of 32% in the last year.

作为投资者,错误是不可避免的。但是,如果你不止一次地面临巨额损失,你就会遇到问题。因此,花点时间同情Scotts Miracle-Gro公司(纽约证券交易所代码:SMG)的长期股东,他们的股价在三年内大幅下跌了76%。那将是一次令人不安的经历。最近的买家也遇到了艰难时期,去年下降了32%。

Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.

由于从长远来看,股东会下跌,让我们来看看那段时间的潜在基本面,看看它们与回报是否一致。

Given that Scotts Miracle-Gro didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Shareholders of unprofitable companies usually expect strong revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

鉴于Scotts Miracle-Gro在过去十二个月中没有盈利,我们将专注于收入增长,以快速了解其业务发展。无利可图的公司的股东通常期望强劲的收入增长。这是因为快速的收入增长可以很容易地推断出来预测利润,通常规模相当大。

In the last three years Scotts Miracle-Gro saw its revenue shrink by 13% per year. That's not what investors generally want to see. The share price fall of 21% (per year, over three years) is a stern reminder that money-losing companies are expected to grow revenue. We're generally averse to companies with declining revenues, but we're not alone in that. There's no more than a snowball's chance in hell that share price will head back to its old highs, in the short term.

在过去的三年中,Scotts Miracle-Gro的收入每年减少13%。这不是投资者普遍希望看到的。股价下跌21%(在三年内每年下跌)严厉地提醒人们,亏损公司有望增加收入。我们普遍反对收入下降的公司,但我们并不是唯一一个这样做的公司。在短期内,股价重回原有高点的可能性不大。

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

您可以在下面看到收入和收入如何随着时间的推移而变化(点击图片了解确切的值)。

earnings-and-revenue-growth
NYSE:SMG Earnings and Revenue Growth February 14th 2024
纽约证券交易所:SMG收益和收入增长 2024年2月14日

If you are thinking of buying or selling Scotts Miracle-Gro stock, you should check out this FREE detailed report on its balance sheet.

如果你想买入或卖出Scotts Miracle-Gro的股票,你应该看看这份关于其资产负债表的免费详细报告。

What About Dividends?

分红呢?

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. As it happens, Scotts Miracle-Gro's TSR for the last 3 years was -74%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence!

除了衡量股价回报率外,投资者还应考虑股东总回报率(TSR)。股东总回报率是一种回报计算方法,它考虑了现金分红的价值(假设收到的任何股息都经过再投资)以及任何贴现资本筹集和分拆的计算价值。因此,对于支付丰厚股息的公司来说,股东总回报率通常远高于股价回报率。碰巧的是,Scotts Miracle-Gro在过去三年的股东总回报率为-74%,超过了前面提到的股价回报率。而且,猜测股息支付在很大程度上解释了这种分歧是没有好处的!

A Different Perspective

不同的视角

Scotts Miracle-Gro shareholders are down 29% for the year (even including dividends), but the market itself is up 19%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 4% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 3 warning signs with Scotts Miracle-Gro (at least 1 which is concerning) , and understanding them should be part of your investment process.

斯科特的Miracle-Gro股东今年下跌了29%(甚至包括股息),但市场本身却上涨了19%。即使是优质股票的股价有时也会下跌,但我们希望在过于感兴趣之前看到企业基本指标的改善。不幸的是,去年的表现可能预示着尚未解决的挑战,因为它比过去五年中4%的年化亏损还要糟糕。总的来说,长期股价疲软可能是一个坏兆头,尽管逆势投资者可能希望研究该股以期出现转机。我发现将长期股价视为业务绩效的代表非常有趣。但是,要真正获得见解,我们还需要考虑其他信息。例如,投资风险的幽灵无处不在。我们已经在Scotts Miracle-Gro上发现了3个警告信号(至少有1个令人担忧),了解它们应该是你投资过程的一部分。

We will like Scotts Miracle-Gro better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我们看到一些重大的内幕收购,我们会更喜欢Scotts Miracle-Gro。在我们等待的同时,请查看这份免费清单,列出了最近有大量内幕收购的成长型公司。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

请注意,本文引用的市场回报反映了目前在美国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发